Navigation Links
Adoption of Minimally Invasive Prostate Cancer Treatment Options Slow

Chemotherapy and Cryosurgery are underused prostate cancer treatments in

the US, according to Millennium Research Group

WALTHAM, Mass., June 25 /PRNewswire/ -- Millennium Research Group (MRG) conducted a detailed survey of over 140 US and European based urologists during the recent 2008 American Urological Association (AUA) Annual Meeting. Results of this study are analyzed in the US and European Urologist Survey: Prostate Cancer Treatment Trends 2008 report. Data from the study suggests that several minimally invasive prostate cancer treatment options are underused in both the US and Europe.

US urologists indicated that cryosurgery was underused, while European urologists felt that both cryosurgery and high-intensity focused ultrasound (HIFU) were underused. In both regions, insufficient data supporting the treatments and the need to refer patients to another specialist were considered the leading barriers to adoption.

"These barriers will need to be addressed before utilization rates can increase notably," says Barbara Prud'homme, Senior Analyst at Millennium Research Group. "Expensive equipment, poor results with early cryosurgery equipment, and physician familiarity with traditional treatments such as radical prostatectomy, have deterred many from performing these minimally invasive procedures. Moreover, many urologists see cryosurgery as a salvage operation after other treatments haven't worked. One positive sign for the adoption of these treatments is that US and European urologists indicated that their use of these treatments had increased over the past year."

Although urologists were underusing new minimally invasive treatments, they were aware of emerging treatment options, including gene therapy and autoimmune therapy. Urologists believed emerging treatments would eventually improve patient outcomes.

MRG's US and European Urologist Survey: Prostate Cancer Treatment Trends 2008 report examines urologists' opinions on some of the industry's most discussed technologies, including permanent implant brachytherapy, high dose rate (HDR) brachytherapy, cryotherapy, and HIFU.

About Millennium Research Group

Millennium Research Group (, a Decision Resources, Inc. company (, is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through published reports, ongoing Marketrack(TM) projects, and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cincinnati Adoption Agency Invited to Participate in Values Voter Presidential Debate
2. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
3. Award recognizes 2 decades of research that led to the adoption of risk adjustment tools
4. MedeFile Applauds U.S. Presidential Hopefuls for Advocating Widespread Adoption of Electronic Medical Records
5. The University of California at San Francisco Medical Center Pioneers System-wide Adoption of Masimo Rainbow SET Technology
6. New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies
7. Gladney Center for Adoption Receives Whole Health Grant from Aetna Foundation
8. The Gladney Center for Adoption Names Mark L. Melson as Executive Vice President/Chief Development Officer
9. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
10. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
11. Published Results Using AtriCure Minimally Invasive Products
Post Your Comments:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology: